Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Ibuprofen

Research Leaders

11 sponsors active, led by China Medical University Hospital

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 1 (1)
Phase 1/2 (1)

Trial Status

Unknown2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT02782650Completed

Prenatal Counseling in Extreme Prematurity: Professionals' View

NCT01207869Phase 1Unknown

Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia

NCT01149564Phase 1/2UnknownPrimary

Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants

Showing all 3 trials

Research Network

Common Treatments

  • Ibuprofen1
  • Ucmscs1
  • Normal Saline1
  • Survey And Interview1

Active Sponsors

  • China Medical University Hospital2
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
  • Leiden University Medical Center1
  • Maxima Medical Center1
  • Isala1

Top Investigators

Related Conditions

  • Severe Bpd That Conventional Therapies Has Failed1
  • Pda1
  • Bronchopulmonary Dysplasia1
  • Oral Ibuprofen1
  • Premature Birth1

Activity Timeline